Legal & General Group Plc purchased a new position in shares of Integer Holdings Corporation (NYSE:ITGR – Free Report) in the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund purchased 76,728 shares of the medical equipment provider’s stock, valued at approximately $7,170,000.
A number of other institutional investors and hedge funds have also recently bought and sold shares of ITGR. Barrow Hanley Mewhinney & Strauss LLC purchased a new position in Integer during the second quarter worth $29,000. EverSource Wealth Advisors LLC lifted its position in shares of Integer by 48.1% in the first quarter. EverSource Wealth Advisors LLC now owns 360 shares of the medical equipment provider’s stock valued at $32,000 after acquiring an additional 117 shares in the last quarter. TD Private Client Wealth LLC boosted its stake in shares of Integer by 1,037.5% during the fourth quarter. TD Private Client Wealth LLC now owns 455 shares of the medical equipment provider’s stock valued at $36,000 after acquiring an additional 415 shares during the last quarter. Parkside Financial Bank & Trust increased its position in Integer by 135.5% during the 4th quarter. Parkside Financial Bank & Trust now owns 464 shares of the medical equipment provider’s stock worth $36,000 after purchasing an additional 267 shares in the last quarter. Finally, Arax Advisory Partners increased its position in Integer by 2,489.5% during the 4th quarter. Arax Advisory Partners now owns 492 shares of the medical equipment provider’s stock worth $39,000 after purchasing an additional 473 shares in the last quarter. Hedge funds and other institutional investors own 99.29% of the company’s stock.
Analyst Upgrades and Downgrades
Several research analysts recently weighed in on the stock. Citigroup boosted their target price on shares of Integer from $92.00 to $96.00 and gave the company a “neutral” rating in a research note on Wednesday, July 8th. Wells Fargo & Company boosted their price objective on shares of Integer from $84.00 to $127.00 and gave the company an “equal weight” rating in a research report on Tuesday, August 4th. Raymond James Financial lowered shares of Integer from a “moderate buy” rating to a “hold” rating in a research report on Monday, August 3rd. Freedom Capital cut shares of Integer from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, August 4th. Finally, Truist Financial downgraded Integer from a “buy” rating to a “hold” rating and boosted their price target for the company from $110.00 to $127.00 in a report on Monday, August 3rd. One analyst has rated the stock with a Buy rating and thirteen have assigned a Hold rating to the company’s stock. Based on data from MarketBeat.com, Integer presently has a consensus rating of “Hold” and a consensus target price of $109.86.
Integer Trading Down 0.1%
Shares of ITGR opened at $125.31 on Thursday. The company has a current ratio of 3.73, a quick ratio of 2.41 and a debt-to-equity ratio of 0.75. The firm has a market capitalization of $4.26 billion, a P/E ratio of 34.24, a price-to-earnings-growth ratio of 2.37 and a beta of 0.62. The stock’s fifty day simple moving average is $109.68 and its 200 day simple moving average is $95.37. Integer Holdings Corporation has a twelve month low of $62.00 and a twelve month high of $126.14.
Integer (NYSE:ITGR – Get Free Report) last issued its earnings results on Monday, August 3rd. The medical equipment provider reported $1.60 earnings per share for the quarter, beating analysts’ consensus estimates of $1.38 by $0.22. Integer had a return on equity of 12.79% and a net margin of 6.97%.The firm had revenue of $464.11 million for the quarter, compared to analysts’ expectations of $451.07 million. During the same quarter last year, the firm earned $1.55 earnings per share. The firm’s revenue for the quarter was down 2.6% compared to the same quarter last year. On average, equities research analysts forecast that Integer Holdings Corporation will post 6.14 earnings per share for the current year.
Integer Company Profile
Integer Holdings Corporation (NYSE: ITGR) is a global provider of outsourced medical device design, development and manufacturing solutions. The company partners with leading medical technology firms to deliver complex components, subsystems and finished devices across a range of therapeutic areas. Its services encompass concept and product design, precision machining, microelectronic assembly, terminal sterilization and regulatory support, enabling customers to accelerate time to market and optimize product performance.
Integer’s product portfolio is organized into two core segments: Advanced Delivery and MedTech.
Recommended Stories
- Five stocks we like better than Integer
- Striking Oil: How the U.S. Play for Venezuela Fuels Supermajors
- J.M. Smucker Stock’s Rally Has More Than Tariffs Behind It
- Wendy’s Rally Fades After Trian Steps Back: Was It Ever Real?
- GitLab’s Earnings Beat Just Gave Software Bulls a New SaaSpocalypse Test
Want to see what other hedge funds are holding ITGR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Integer Holdings Corporation (NYSE:ITGR – Free Report).
Receive News & Ratings for Integer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Integer and related companies with MarketBeat.com's FREE daily email newsletter.
